Korro Bio Inc (KRRO)
50.13
-4.88
(-8.87%)
USD |
NASDAQ |
Nov 14, 16:00
49.37
-0.76
(-1.52%)
After-Hours: 17:33
Korro Bio Max Drawdown (5Y): 99.61% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.61% |
| September 30, 2024 | 99.61% |
| August 31, 2024 | 99.61% |
| July 31, 2024 | 99.61% |
| June 30, 2024 | 99.61% |
| May 31, 2024 | 99.61% |
| April 30, 2024 | 99.61% |
| March 31, 2024 | 99.61% |
| February 29, 2024 | 99.61% |
| January 31, 2024 | 99.61% |
| December 31, 2023 | 99.61% |
| November 30, 2023 | 99.61% |
| October 31, 2023 | 99.61% |
| September 30, 2023 | 99.40% |
| August 31, 2023 | 99.40% |
| July 31, 2023 | 99.40% |
| June 30, 2023 | 99.40% |
| May 31, 2023 | 99.36% |
| April 30, 2023 | 99.35% |
| March 31, 2023 | 99.21% |
| February 28, 2023 | 98.80% |
| January 31, 2023 | 98.13% |
| December 31, 2022 | 98.13% |
| November 30, 2022 | 98.13% |
| October 31, 2022 | 98.13% |
| Date | Value |
|---|---|
| September 30, 2022 | 98.13% |
| August 31, 2022 | 98.13% |
| July 31, 2022 | 98.13% |
| June 30, 2022 | 98.13% |
| May 31, 2022 | 97.98% |
| April 30, 2022 | 97.64% |
| March 31, 2022 | 96.91% |
| February 28, 2022 | 94.84% |
| January 31, 2022 | 91.33% |
| December 31, 2021 | 91.00% |
| November 30, 2021 | 90.73% |
| October 31, 2021 | 88.58% |
| September 30, 2021 | 87.35% |
| August 31, 2021 | 87.04% |
| July 31, 2021 | 86.31% |
| June 30, 2021 | 85.48% |
| May 31, 2021 | 85.48% |
| April 30, 2021 | 85.48% |
| March 31, 2021 | 85.48% |
| February 28, 2021 | 46.82% |
| January 31, 2021 | 46.82% |
| December 31, 2020 | 46.82% |
| November 30, 2020 | 46.82% |
| October 31, 2020 | 46.82% |
| September 30, 2020 | 46.82% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
9.50%
Minimum
Nov 2019
99.61%
Maximum
Oct 2023
80.62%
Average
97.81%
Median
Max Drawdown (5Y) Benchmarks
| Marker Therapeutics Inc | 99.42% |
| Pliant Therapeutics Inc | -- |
| CEL-SCI Corp | 96.78% |
| AIM ImmunoTech Inc | 99.61% |
| IGC Pharma Inc | 97.77% |